Vet Molecular Diagnostics Market is estimated to increase at a Compounded Annual Growth Rate of 9.2% CAGR over the forecast period from 2024 to 2030
The Vet Molecular Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Instruments, Kit and Reagents, Software and Services), By Application (Infectious Diseases, Genetics, Others), By Technology (PCR, Microarray, DNA Sequencing).
An Introduction to Vet Molecular Diagnostics Market in 2024
In 2024, the market for veterinary molecular diagnostics continues to expand, offering advanced tools and technologies for the diagnosis, monitoring, and management of animal diseases across companion animals, livestock, and wildlife species. Veterinary molecular diagnostics encompass a wide range of techniques such as polymerase chain reaction (PCR), nucleic acid sequencing, and microarray analysis, which enable the detection and characterization of pathogens, genetic mutations, and biomarkers associated with infectious diseases, genetic disorders, and cancer in animals. With advancements in assay sensitivity, specificity, and automation, veterinary molecular diagnostics offer rapid, accurate, and high-throughput testing solutions for veterinarians, veterinary laboratories, and animal health researchers. Moreover, the market is influenced by trends such as the development of point-of-care molecular testing platforms for on-site diagnosis and surveillance in veterinary clinics and field settings, the expansion of molecular test menus to include emerging and zoonotic pathogens, and the integration of molecular diagnostics into integrated disease management programs and One Health initiatives. Additionally, ongoing research focuses on expanding the utility of molecular diagnostics for veterinary applications, validating novel biomarkers and diagnostic assays for different animal species and diseases, and translating research findings into clinical practice guidelines and veterinary diagnostic algorithms, reflecting the continuous innovation and advancement in veterinary molecular diagnostics to improve animal health, welfare, and disease control.
Market Trend: Expansion of Point-of-Care Testing
One prominent market trend in veterinary molecular diagnostics is the expansion of point-of-care testing. With advancements in technology and increased demand for rapid and accurate diagnostic results, there is a growing trend towards the development and adoption of point-of-care molecular diagnostic tests in veterinary medicine. These tests enable veterinarians to quickly diagnose infectious diseases, genetic disorders, and cancer in animals directly at the point of care, without the need for sending samples to external laboratories. The expansion of point-of-care testing offers benefits such as rapid turnaround times, immediate treatment initiation, and improved patient outcomes, driving its adoption in veterinary clinics, shelters, and mobile veterinary practices.
Market Driver: Growing Awareness of Zoonotic Diseases and Food Safety Concerns
A significant market driver for veterinary molecular diagnostics is the growing awareness of zoonotic diseases and food safety concerns. Zoonotic diseases are infectious diseases that can be transmitted between animals and humans, posing significant public health risks. Additionally, foodborne pathogens and contaminants can compromise food safety and lead to outbreaks of foodborne illnesses. Veterinary molecular diagnostics play a crucial role in the early detection, surveillance, and control of zoonotic diseases in animals, as well as in monitoring foodborne pathogens in livestock and food production environments. The increasing emphasis on zoonotic disease surveillance, One Health initiatives, and food safety regulations drives the demand for veterinary molecular diagnostics as essential tools for protecting animal and human health.
Market Opportunity: Development of Companion Animal Molecular Diagnostic Tests
One potential opportunity in the veterinary molecular diagnostics market lies in the development of companion animal-specific molecular diagnostic tests. While many molecular diagnostic tests are currently available for livestock and production animals, there is a growing demand for tests tailored to the unique needs of companion animals such as dogs, cats, and horses. Opportunities exist to develop molecular tests for genetic diseases, breed-specific conditions, infectious diseases, and cancer biomarkers that are relevant to companion animal health. Companion animal molecular diagnostic tests can enable early disease detection, personalized treatment plans, and improved management of chronic conditions, enhancing the quality of care for pets and strengthening the bond between owners and their animal companions. By capitalizing on opportunities to develop companion animal-specific molecular diagnostic tests, manufacturers can expand their product portfolios, address unmet clinical needs, and tap into the growing pet healthcare market.
Vet Molecular Diagnostics Market Share Analysis: Kit and Reagents for Infectious Diseases
In the Vet Molecular Diagnostics Market, the segment experiencing rapid growth is Kit and Reagents for Infectious Diseases. With the increasing awareness of zoonotic diseases and the need for effective disease management in veterinary medicine, there is a growing demand for molecular diagnostic kits and reagents specifically designed to detect infectious diseases in animals. These kits and reagents offer convenience, accuracy, and rapid results, enabling veterinarians to quickly diagnose infectious diseases and implement appropriate treatment strategies. Additionally, advancements in technology have led to the development of multiplex assays and point-of-care testing kits, further driving the adoption of molecular diagnostic kits and reagents for infectious diseases in veterinary practice. As veterinary clinics, diagnostic laboratories, and research institutions prioritize the detection and control of infectious diseases in animals, the kit and reagents segment for infectious diseases is expected to witness significant growth in the vet molecular diagnostics market.
Vet Molecular Diagnostics Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBiochek BV, Biomedica Group, Biomerieux SA, Bioneer Corp, Idexx Laboratories Inc, Ingenetix GmbH, Neogen Corp, Novacyt Group, QIAGEN N.V., Thermo Fischer Scientific Inc, Veterinary Molecular Diagnostics Inc, Virbac SA
Vet Molecular Diagnostics Market Segmentation
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Vet Molecular Diagnostics Market Companies
Biochek BV
Biomedica Group
Biomerieux SA
Bioneer Corp
Idexx Laboratories Inc
Ingenetix GmbH
Neogen Corp
Novacyt Group
QIAGEN N.V.
Thermo Fischer Scientific Inc
Veterinary Molecular Diagnostics Inc
Virbac SA
Reasons to Buy the Vet Molecular Diagnostics Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Vet Molecular Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Vet Molecular Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Vet Molecular Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Vet Molecular Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Vet Molecular Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Vet Molecular Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Vet Molecular Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Vet Molecular Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Vet Molecular Diagnostics Industry
4.2 Key Market Trends in Vet Molecular Diagnostics Industry
4.3 Potential Opportunities in Vet Molecular Diagnostics Industry
4.4 Key Challenges in Vet Molecular Diagnostics Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Vet Molecular Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Vet Molecular Diagnostics Market Outlook by Segments
7.1 Vet Molecular Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
8 North America Vet Molecular Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Vet Molecular Diagnostics Markets in 2024
8.2 North America Vet Molecular Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Vet Molecular Diagnostics Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
9 Europe Vet Molecular Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Vet Molecular Diagnostics Markets in 2024
9.2 Europe Vet Molecular Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Vet Molecular Diagnostics Market Size Outlook by Segments, 2021-2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
10 Asia Pacific Vet Molecular Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Vet Molecular Diagnostics Markets in 2024
10.2 Asia Pacific Vet Molecular Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Vet Molecular Diagnostics Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
11 South America Vet Molecular Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Vet Molecular Diagnostics Markets in 2024
11.2 South America Vet Molecular Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Vet Molecular Diagnostics Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
12 Middle East and Africa Vet Molecular Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Vet Molecular Diagnostics Markets in 2024
12.2 Middle East and Africa Vet Molecular Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Vet Molecular Diagnostics Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Biochek BV
Biomedica Group
Biomerieux SA
Bioneer Corp
Idexx Laboratories Inc
Ingenetix GmbH
Neogen Corp
Novacyt Group
QIAGEN N.V.
Thermo Fischer Scientific Inc
Veterinary Molecular Diagnostics Inc
Virbac SA
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Instruments
Kit and Reagents
Software and Services
By Application
Infectious Diseases
Genetics
Others
By Technology
PCR
Microarray
DNA Sequencing
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
